Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Alpha-1 antitrypsin (inhalation use)

EU orphan designation number: EU/3/04/244   
Active ingredient: Alpha-1 antitrypsin (inhalation use)
Indication: Treatment of emphysema secondary to congenital alpha-1 antitrypsin deficiency
Sponsor: Kamada BioPharma Limited
Riverbank House, 2 Swan Lane, London EC4R 3TT, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/11/2004 Orphan designation EMEA/OD/054/04 (2004)4467 of 16/11/2004
27/06/2007 Transfer of orphan designation EMEA/OD/054/04/T/01 (2007)3178 of 25/06/2007
11/12/2007 Change of name and/or address of sponsor
01/04/2009 Transfer of orphan designation EMEA/OD/054/04/T/02 (2009)2490 of 27/03/2009
09/11/2010 Change of name and/or address of sponsor EMA/581017/2010
18/05/2011 Transfer of orphan designation EMEA/OD/054/04/T/03 (2011)3478 of 13/05/2011
17/12/2012 Change of name and/or address of sponsor
29/07/2013 Transfer of orphan designation EMEA/OD/054/04/T/04 (2013)4955 of 25/07/2013
23/01/2014 Change of name and/or address of sponsor
24/02/2016 Transfer of orphan designation EMA/OD/054/04/T/05 (2016)1116 of 17/02/2016